1. Magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer. Issue 2 (February 2019) Authors: Golshan, M.; Wong, S.; Loibl, S.; Huober, J.B.; O'Shaughnessy, J.; Rugo, H.S.; Wolmark, N.; McKee, M.D.; Maag, D.; Sullivan, D.M.; Metzger-Filho, O.; Von Minckwitz, G.; Geyer, C.E.; Sikov, W.M.; Untch, M. Journal: European journal of surgical oncology Issue: Volume 45:Issue 2(2019) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial. (November 2018) Authors: Hurvitz, S.A.; Quek, R.G.W.; Turner, N.C.; Telli, M.L.; Rugo, H.S.; Mailliez, A.; Ettl, J.; Grischke, E.; Mina, L.A.; Balmaña, J.; Fasching, P.A.; Bhattacharyya, H.; Hannah, A.L.; Robson, M.E.; Wardley, A.M. Journal: European journal of cancer Issue: Volume 104(2018) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Real-world treatment patterns and outcomes of palbociclib in combination with an aromatase inhibitor in the US older patients with metastatic breast cancer. (December 2021) Authors: Rugo, H.S.; Liu, X.; Li, B.; McRoy, L.; Layman, R.M.; Brufsky, A. Journal: Journal of geriatric oncology Issue: Volume 12(2021)Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SA 9.1 Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer. (April 2023) Authors: Rugo, H.S. Journal: Breast Issue: Volume 68(2023)Supplement Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗